This study evaluated the effects of ATRA on annexin A2 and S100A10 expression, plasmin activation, and the ability of ATRA to inhibit serous ovarian cancer cell survival and invasion. The gene discussed is S100A10; the disease is ovarian serous adenocarcinoma.